HTAi: A Global Collaboration Laura Sampietro-Colom, MD, PhD Deputy Director Innovation. Hospital Clinic Barcelona HTAi Immediate Past President
Index 1. Why a Global Collaboration in HTA? 2. What HTAi is? 3. HTAi and global collaboration in HTA 4. Final thoughts
Why a Global Collaboration in HTA?: 1rst Innovation at any price Shifting paradigm Innovation at value based reimbursemen t/price
Why a Global Collaboration in HTA?: 2nd Survival depends on cooperation/ collaboration You may consider yourself an individual, but I can tell you that you are in a truth a cooperative community of approximately fifty trillion single-celled citizens. Almost all of your cells that make up your body are amoeba-like, individual organisms that have evolved a cooperative strategy for their mutual survival Lipthon B H, PhD (Cell biologists). The Biology of Believe. 2008
Why a Global Collaboration?: 3rd NETWORKS META- NETWORKS Globalize Knowledge Localize decisions
Why a Global Collaboration?: 3rd Localize decisions Many stakeholders Regulatory agencies Governments Payers Providers Industry Patients Conflicting goals and incentives Safety/efficacy/effe ctiveness Access to services Profitability High quality Cost containment Convenience Patient centeredness Satisfaction
What HTAi is? 1. The only interdisciplinar international scientific & professional society focusing specifically in HTA Meeting point Building Together
What HTAi is? 2. Scientific & health care policy science for appropriate HT access and use Network
What HTAi is? Individuals HTA Agencies National/Federal Governments 3. Network for Global thinking HTA diffusion & Local action Regional Governments Insurance Companies HealthTech industry Hospitals Primary care
HTAi: The Scientific & Professional Society 52 Not-for-profit organizational members 16 For-profit organizational members # of members/continent Africa 7 Asia 86 Oceania 56 Europe 380 North America 222 South America 588 TOTAL MEMBERS 1339
HTAi: The Scientific & Professional Society Privat
HTAi: The Scientific & Professional Society U.S.A Non-for-Profit Organizational Members = 52 Canada
HTAi: The Scientific & Professional Society U.K. Non-for-Profit Organizational Members Spain Germany
HTAi: The Scientific & Professional Society Non-for-Profit Organizational Members Other European countries SPC on Standardization and HTA
HTAi: The Scientific & Professional Society Non-for-Profit Organizational Members Australia and New Zealand Asia
Europe: Clustering National HTA organizations by their role in the assessment process Perform the assessment and recommend (others take final decision) (eg. SBU, DACEHTA, HAS, Spanish National & Regional Agencies) Perform a section of assessment (but own final report), commission some sections, and recommend (others take final decision) (eg. IQWiG, DAHTA, UVKL) Mainly commission all the assessments and takes decisions on coverage (eg. G-BA, NICE (MTA), AWSMG, AIFA) Industry perform the assessment, institutions check the quality (redo model if needed) (eg. CVZ-CHT, TVL, SMC, NICE (STA))
Europe: Weight of Clinical & Economic outcomes in final recommendation Clinical NICE, SMC, AWMSG SBU, TVL Spanish Institutions Regions NICE, SMC, AWMSG CVZ (orientative) G-BA IQWiG CVZ HAS INCA AIFA (up to now)
Europe: Looking at economics Always QALY based CEA NICE, SMC, AWMSG CVZ-CHT * TVL AIFA (recently) * If new treatment show clinical added value UVKL GB-A HAS BIA Regions DK, Italy, Spain, Sweden Hospitals (all) Primary Care Trusts (UK) Other economics IQWiG * (CEA, recently) GB-A (CEA, recently) DACEHTA (CEA) HAS (post-assessment added value,post launch) Sometimes SBU (CUA, CEA, BIA) DAHTA (BIA) Spanish and Italian Regions (CEA)
HTAi: The Scientific & Professional Society For-Profit Organizational Members = 16
HTAi & Global Collaboration in HTA 1. Annual Meetings 2. Travel & Educational Grants Travel grants for Low and Middle income countries to Annual Meeting Educational grants for LMIC Jill Sanders Scholarship (Africa)
HTAi & Global Collaboration in HTA 3. Interest Subgroups Early Career Network (launched 2011) 99 members Conditional coverage/access with evidence 247 members HTA in developing countries 98 members Disinvestment of obsolete or low added value 93 members technologies Ethics in HTAi 44 members Hospital-based HTA 96 members HTA Regulatory Interactions (launched 2012) 4 members Information resources 179 members Patient and citizen involvement in HTA 148 members
HTAi & Global Collaboration in HTA 4. The web: www.htai.org
HTAi & Global Collaboration in HTA 4.1. The web: Vortal
HTAi & Global Collaboration in HTA 5. 6.
HTAi & Global Collaboration in HTA 7. The Journal Egon Jonson Award for best paper
HTAi & Global Collaboration in HTA 8. The HTAi Policy Forum to facilitate productive interactions between health care decision makers and industry to really bring industry, government and HTA agencies working at the point of decision making together. Born in 2005 in London to have an open discussion of challenges so that different perspectives and limitations can be better understood Members 2012: Non-for profit=14 / For profit=14
HTAi & Global Collaboration in HTA 8. The HTAi Policy Forum Chatham House Rule When a meeting, or part thereof, is held under the Chatham House Rule, participants are free to use the information received, but neither the identity nor the affiliation of the speaker(s), nor that of any other participant, may be revealed.
HTAi & Global Collaboration in HTA 8. The HTAi Policy Forum Promoting Clinically Relevant Innovation and managing Uncertainty: the role of the HTA process (6-7 Februry 2005, UK) Rethinking Regulation and HTA (5-7 February, 2006 Virginia, USA) Conditional Reimbursement / Coverage with Evidence (11-13 February 2007, Zeist, Netherlands) Harmonizing Evidence Requirements for HTA in decision Making (10-12 February 2008, Rome, Italy) HTA for optimization of technology utilization (8-10 February, San Francisco, USA) Managed Entry Schemes (31 January -2 February 2010, Washington D.C., USA) HTA and Regulation (30 January-1 February 2011, London) HTA and disinvestment (San Francisco, 2012)
HTAi & Global Collaboration in HTA 9. MoU 52 members 26 countries 1. Annual Meeting (after HTAi) 2. Joint ISG 3. Bidirectional Communication with members 1. First Global Forum on Medical Devices (MD) 2. Call for Innovative MD 3. Workshops at HTAi meeting 4. Web-casting developing countries Pre-conference meeting (2011) Participation in plenary (2011) ISG Emerging Technologies expected
HTAi & Global Collaboration in HTA 10. HTA Glossary: HTAi, INAHTA, GIN, ISQUA 11. 1st Regional Meetings (LAC) (PAHO, Mercosur, MoH Brazil and Argentina, IECS) (2010). 2nd expected 2012 12. Society for Medical Decision Making: Post-conference ½ day meeting (Nov. 2010), web-cast. Personalized Medicine (2012) 13. Workshops with Regulatory Agencies (medicines and Devices) (February & October 2011) 14. Workshops with MoH (Argentina 2010, PAHO 2010, China 2011) 15. Promoting presence of HTA International networks in HTAi Annual Meetings (EUnetHTA, INAHTA, EuroScan)
What can HTAi offer in a global world? Friendly and open-mind space for networking: Crossfertilization Robust grounded space for discussion of: HTA methods practices and Health policy science regarding HTs Ways to implement HTA results into systems and clinical practices Dynamic an interactive space for evolving the science of both methods and health policy for a wise promotion (innovative) and recall (obsolete) HTs. Neutral place of dialog between those who produce HTA, those responsible for HTA based coverage and health care practice decisions, and industry.
Final thoughts International/Global collaboration as an imperative today Highly needed for survival and evolution Background of HTAi is to promote and foster global collaboration If you want to be part of the global HTA community, HTAi is your place!
Thank You!